French medical imaging firm Guerbet H1 EBITDA margin falls on Raleigh site costs

Guerbet SA

28/09/2026 16:56

Overview
France medical imaging firm's H1 2026 revenue nearly flat at CER and like-for-like
H1 restated EBITDA margin fell to 9.1% due to €14.3 mln in exceptional Raleigh site costs
Company confirms all 2026 financial targets despite ongoing refinancing discussions

Outlook
Guerbet confirms 2026 revenue to be stable or down slightly at CER and like-for-like
Company targets 2026 restated EBITDA margin of around 8%, including about €35 mln Raleigh costs
Guerbet expects 2026 free cash flow between -€50 mln and -€70 mln

Result Drivers
RALEIGH SITE COSTS - Exceptional costs from remediation plan at Raleigh site weighed on profitability
REGIONAL VARIATION - Growth in France and Americas offset by decline in Asia, mainly China, due to healthcare spending cuts and market restructuring
TRANSFORMATION PLAN - Operational efficiency measures and commercial revitalization underway to restore growth and improve margins

Company press release: ID:nGNE1dqzmH

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
H1 EBITDA
 
EUR 30.60 mln
 
H1 Restated EBITDA Margin
 
9.10%
 

Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy", 2 "hold" and 1 "sell" or "strong sell"
Wall Street's median 12-month price target for Guerbet SA is €8.30, about 18.1% above its September 25 closing price of €7.03
The stock recently traded at 89 times the next 12-month earnings vs. a P/E of 10 three months ago

Reuters Recommended Reads
Sept 28 - France's Inventiva H1 net loss narrows
Sept 28 - France's Equasens H1 profit up 10.5%, helped by acquisitions
Sept 25 - France can't count on ECB to fix debt woes, central bank chief says

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)